Bio Protocol vs DeXe — how do they compare? Bio Protocol trades at Rp517.08 (market cap Rp1,15T, Rp260,42M 24h volume), while DeXe trades at Rp728,476 (market cap Rp61,16T, Rp2,56T 24h volume). The key difference: DeXe is far larger — about 53.2× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while DeXe's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and DeXe for 11 Days on average.
| BIO | DEXE | |
|---|---|---|
Market Cap | Rp1,15T | Rp61,16T |
Volume (24h) | Rp260,42M | Rp2,56T |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 83,7M DEXE |
Typical Hold Time | 16 Days | 11 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
DEXE is trading at Rp759,087 with a bullish technical signal, supported by moving averages and strong ADX readings, though RSI indicates overbought conditions. The token is positioned between support at Rp727,579 and resistance at Rp943,755. No major protocol updates or ecosystem news are reported recently, with on-chain activity showing an average hold time of 11 days.
Overall outlook is cautiously optimistic due to technical strength, but risks include high volatility from overbought RSI and limited liquidity. Key opportunities lie in breaking resistance for further gains, while major risks involve potential pullbacks and regulatory uncertainties in the crypto space.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →The DeXe Protocol is a flexible and merit-based infrastructure for creating and managing DAOs. It ensures proper incentives and active member participation, helping DAOs grow efficiently and sustainably. Governed by the DeXe DAO, its governance token, $DEXE, plays a key role in decision-making.
Read more on DEXE →